Your browser doesn't support javascript.
loading
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
Yang, Qing; Saldi, Tassa K; Lasda, Erika; Decker, Carolyn J; Paige, Camille L; Muhlrad, Denise; Gonzales, Patrick K; Fink, Morgan R; Tat, Kimngan L; Hager, Cole R; Davis, Jack C; Ozeroff, Christopher D; Meyerson, Nicholas R; Clark, Stephen K; Fattor, Will T; Gilchrist, Alison R; Barbachano-Guerrero, Arturo; Worden-Sapper, Emma R; Wu, Sharon S; Brisson, Gloria R; McQueen, Matthew B; Dowell, Robin D; Leinwand, Leslie; Parker, Roy; Sawyer, Sara L.
Afiliação
  • Yang Q; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Saldi TK; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Lasda E; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Decker CJ; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Paige CL; Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Muhlrad D; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Gonzales PK; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Fink MR; Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Tat KL; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Hager CR; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Davis JC; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Ozeroff CD; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Meyerson NR; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Clark SK; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Fattor WT; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Gilchrist AR; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Barbachano-Guerrero A; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Worden-Sapper ER; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Wu SS; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Brisson GR; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • McQueen MB; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Dowell RD; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Leinwand L; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Parker R; BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
  • Sawyer SL; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.
medRxiv ; 2021 Mar 05.
Article em En | MEDLINE | ID: mdl-33688663
ABSTRACT
We analyze data from the Fall 2020 pandemic response efforts at the University of Colorado Boulder (USA), where more than 72,500 saliva samples were tested for SARS-CoV-2 using quantitative RT-PCR. All samples were collected from individuals who reported no symptoms associated with COVID-19 on the day of collection. From these, 1,405 positive cases were identified. The distribution of viral loads within these asymptomatic individuals was indistinguishable from what has been previously reported in symptomatic individuals. Regardless of symptomatic status, approximately 50% of individuals who test positive for SARS-CoV-2 seem to be in non-infectious phases of the disease, based on having low viral loads in a range from which live virus has rarely been isolated. We find that, at any given time, just 2% of individuals carry 90% of the virions circulating within communities, serving as viral "super-carriers" and possibly also super-spreaders.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos